Your browser doesn't support javascript.
loading
Validation of the DNA Damage Immune Response Signature in Patients With Triple-Negative Breast Cancer From the SWOG 9313c Trial.
Sharma, Priyanka; Barlow, William E; Godwin, Andrew K; Parkes, Eileen E; Knight, Laura A; Walker, Steven M; Kennedy, Richard D; Harkin, Denis P; Logan, Gemma E; Steele, Christopher J; Lambe, Shauna M; Badve, Sunil; Gökmen-Polar, Yesim; Pathak, Harsh B; Isakova, Kamilla; Linden, Hannah M; Porter, Peggy; Pusztai, Lajos; Thompson, Alastair M; Tripathy, Debu; Hortobagyi, Gabriel N; Hayes, Daniel F.
Afiliación
  • Sharma P; University of Kansas Medical Center, Westwood, KS.
  • Barlow WE; SWOG Statistical Center, Seattle, WA.
  • Godwin AK; University of Kansas Medical Center, Kansas City, KS.
  • Parkes EE; Queen's University Belfast, Belfast, UK.
  • Knight LA; Queen's University Belfast, Belfast, UK.
  • Walker SM; Almac Group, Craigavon, UK.
  • Kennedy RD; Queen's University Belfast, Belfast, UK.
  • Harkin DP; Almac Group, Craigavon, UK.
  • Logan GE; Queen's University Belfast, Belfast, UK.
  • Steele CJ; Almac Group, Craigavon, UK.
  • Lambe SM; Queen's University Belfast, Belfast, UK.
  • Badve S; Almac Group, Craigavon, UK.
  • Gökmen-Polar Y; Almac Group, Craigavon, UK.
  • Pathak HB; Almac Group, Craigavon, UK.
  • Isakova K; Almac Group, Craigavon, UK.
  • Linden HM; Indiana University School of Medicine, Indianapolis, IN.
  • Porter P; Indiana University School of Medicine, Indianapolis, IN.
  • Pusztai L; University of Kansas Medical Center, Kansas City, KS.
  • Thompson AM; University of Kansas Medical Center, Kansas City, KS.
  • Tripathy D; University of Washington, Seattle, WA.
  • Hortobagyi GN; Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Hayes DF; Fred Hutchinson Cancer Research Center, Seattle, WA.
J Clin Oncol ; 37(36): 3484-3492, 2019 12 20.
Article en En | MEDLINE | ID: mdl-31657982

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores de Tumor / Neoplasias de la Mama Triple Negativas Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: J Clin Oncol Año: 2019 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores de Tumor / Neoplasias de la Mama Triple Negativas Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: J Clin Oncol Año: 2019 Tipo del documento: Article